Log in to your Inderes Free account to see all free content on this page.
Coloplast
443.10 DKK
+2.24 %
Less than 1K followers
COLO B
NASDAQ Copenhagen
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Coloplast
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 17,939.0 | 18,544.0 | 19,426.0 | 22,579.0 | 24,500.0 | 27,030.0 | 27,874.0 |
| growth-% | 3.4 % | 4.8 % | 16.2 % | 8.5 % | 10.3 % | 3.1 % | |
| EBITDA | 5,807.0 | 6,705.0 | 6,947.0 | 7,369.0 | 7,840.0 | 8,610.0 | 9,123.0 |
| EBIT | 5,156.0 | 5,854.0 | 6,155.0 | 6,439.0 | 6,771.0 | 7,320.0 | 7,201.0 |
| Profit before taxes | 5,028.0 | 5,466.0 | 6,233.0 | 6,127.0 | 6,025.0 | 6,395.0 | 6,157.0 |
| Net income | 3,873.0 | 4,197.0 | 4,825.0 | 4,706.0 | 4,783.0 | 5,052.0 | 3,636.0 |
| EPS | 18.32 | 19.86 | 22.83 | 22.14 | 22.21 | 22.46 | 16.13 |
| Dividend | 17.00 | 18.00 | 19.00 | 20.00 | 21.00 | 22.00 | 18.00 |
| Dividend ratio | 92.8 % | 90.6 % | 83.2 % | 90.3 % | 94.6 % | 98.0 % | 111.6 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | 32.4 % | 36.2 % | 35.8 % | 32.6 % | 32.0 % | 31.9 % | 32.7 % |
| EBIT-% | 28.7 % | 31.6 % | 31.7 % | 28.5 % | 27.6 % | 27.1 % | 25.8 % |
| ROE | 56.0 % | 56.7 % | 59.1 % | 56.8 % | 27.6 % | 28.2 % | 22.6 % |
| ROI | 30.4 % | 31.1 % | 30.5 % | 13.5 % | 9.9 % | 10.5 % | 7.5 % |
Login required
This content is only available for logged in users